Briacell Therapeutics Corp Stock Statistic Functions Linear Regression Slope

BCT Stock   5.73  -0.17  -2.88%   
The statistic functions view organizes Linear Regression Slope function and supporting indicators around Briacell Therapeutics. The analysis highlights statistical functions describing dispersion and variability and frames technical signals with volatility and risk context.Select Time Period to execute this module.

Execute Function
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Slope is the rate of change in Briacell Therapeutics price series over its benchmark or peer price series.

Briacell Therapeutics Technical Analysis Modules

Most technical analysis of Briacell Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Briacell from various momentum indicators to cycle indicators. When you analyze Briacell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Downside history and drawdown behavior provide context for risk expectations in Briacell Therapeutics. Past price movements indicate comparatively limited downside dispersion. Briacell Therapeutics has a market cap of 42.78 M, ROE of -4.44%.

Methodology

Unless otherwise specified, financial data for Briacell Therapeutics Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Briacell (CA:BCT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Briacell Therapeutics Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board

Become your own money manager

Tracking Briacell Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Momentum Idea
Momentum
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
Advertising Idea
Advertising
Invested few shares
Social Domain Idea
Social Domain
Invested few shares

More Resources for Briacell Stock Analysis

A structured review of Briacell Therapeutics often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Briacell Therapeutics Corp Stock. Highlighted below are reports that provide context for Briacell Therapeutics Corp Stock:
Briacell Therapeutics has a market cap of 42.78 M, ROE of -4.44%. Trending Equities can help frame allocation decisions. The allocation includes a position in Briacell Therapeutics Corp inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Analysis related to Briacell Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Value and price for Briacell Therapeutics are related but not identical, and they can diverge across cycles. For Briacell Therapeutics, key inputs include a P/B ratio of 3.15, and ROE of -4.44%. By contrast, market price reflects the level where buyers and sellers transact.